Praxis will receive an upfront payment from UCB, and if the option is exercised by UCB, would be eligible to receive an option fee and future success-based development and commercialization milestone payments, for a total of up to ~$100M, in addition to tiered royalties on net sales of any resulting products from the collaboration.
Stock up 2.3% after-hours.
It has been a troublesome 13 months for buyers as a mixture of things has stored the market usually unstable...
Tesla has as soon as once more ignited a fierce debate over government compensation, company governance and efficiency incentives with...
This text was written byComply withThe World Gold Council is the market improvement group for the gold business. Our function...
HDFC Financial institution is predicted to clock a standalone revenue of Rs 17,345.41 crore for the quarter, with its Web...
A part of the decolonisation effort includes a aware effort to reclaim and worth India’s cultural heritage, beforehand usually undervalued...
Searching for Alpha's Disclaimer: The earnings name insights are compilations of earnings name transcripts and different content material out there...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
